AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $8.879M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 11.59am 06/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 2.3¢ | Day High | 2.3¢ | Day Low | 2.3¢ | |||
| Daily Volume | 19653 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 2.3¢ | 29379 | 0 | 2.4¢ | 75214 | |
Directors & Senior Management
| Mr. Andrew Wallace Guthrie | Non-Executive Director |
| Prof. Catherine Hill | Member of the Scientific Advisory Board |
| Mr. Christopher Mark Ramsay | Non-Executive Director |
| Mr. Drew Speedy | CFO & Company Secretary |
| Mr. Huong Soo Ding | Non-Executive Chairman |
| Mr. Neil Anderson | Member of Scientific Advisory Board |
| Mr. Peter Donald May | Executive Director of Research & Development and Executive Director |
| Mr. Timothy Owen Grogan | MD, CEO & Director |
Data source: ADVFN
